A new trading day began on Friday, with Conmed Corp (NYSE: CNMD) stock price down -9.43% from the previous day of trading, before settling in for the closing price of $44.24. CNMD’s price has ranged from $40.16 to $76.34 over the past 52 weeks.
During the last 5-year period, the sales growth of Healthcare Sector giant was 34.38%. Meanwhile, its annual earnings per share averaged 7.95%. With a float of $30.02 million, this company’s outstanding shares have now reached $30.96 million.
Conmed Corp (CNMD) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Conmed Corp is 3.05%, while institutional ownership is 109.70%. The most recent insider transaction that took place on Nov 21 ’25, was worth 10,591. In this transaction Chief Information Officer of this company sold 257 shares at a rate of $41.21, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 21 ’25, when Company’s Officer proposed sale 257 for $41.21, making the entire transaction worth $10,591.
Conmed Corp (CNMD) Recent Fiscal highlights
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 1.34 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.95 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 7.95% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 7.28% during the next five years compared to 34.38% growth over the previous five years of trading.
Conmed Corp (NYSE: CNMD) Trading Performance Indicators
Here are Conmed Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.92. Likewise, its price to free cash flow for the trailing twelve months is 8.33.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.06, a number that is poised to hit 1.32 in the next quarter and is forecasted to reach 4.54 in one year’s time.
Technical Analysis of Conmed Corp (CNMD)
Looking closely at Conmed Corp (NYSE: CNMD), its last 5-days average volume was 0.63 million, which is a jump from its year-to-date volume of 0.47 million. As of the previous 9 days, the stock’s Stochastic %D was 56.13%.
During the past 100 days, Conmed Corp’s (CNMD) raw stochastic average was set at 6.33%, which indicates a significant decrease from 17.05% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.62 in the past 14 days, which was lower than the 1.69 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $44.80, while its 200-day Moving Average is $52.22. However, in the short run, Conmed Corp’s stock first resistance to watch stands at $42.86. Second resistance stands at $45.64. The third major resistance level sits at $47.60. If the price goes on to break the first support level at $38.12, it is likely to go to the next support level at $36.16. Now, if the price goes above the second support level, the third support stands at $33.38.
Conmed Corp (NYSE: CNMD) Key Stats
With a market capitalization of 1.24 billion, the company has a total of 30,968K Shares Outstanding. Currently, annual sales are 1,307 M while annual income is 132,420 K. The company’s previous quarter sales were 337,930 K while its latest quarter income was 2,860 K.
